Skip to content

The pulmonary protective effect of continuous inhalation of esketamine in elderly patients undergoing laparoscopic radical resection of colorectal cancer

The pulmonary protective effect of continuous inhalation of esketamine in elderly patients undergoing laparoscopic radical resection of colorectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099758
Enrollment
Unknown
Registered
2025-03-28
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pulmonary complications

Interventions

N group:Aerosol inhalation of saline
KI group:Aerosol inhalation of esketamine
KV group:Intravenous pump infusion of esketamine

Sponsors

Nantong First People's Hispital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 84 Years

Inclusion criteria

Inclusion criteria: Patients who are to undergo laparoscopic radical colorectal cancer resection under general anesthesia were selected, aged 60 to 84 years old, ASA grade I~III., BMI 18.5-30kg/m^2, male or female.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiovascular and cerebrovascular diseases; 2. Patients with severe liver and kidney dysfunction; 3. The preoperative pulmonary function test value is lower than 65% of the predicted value; 4. Long-term opioid users; 5. Patients with lung infection or systemic infection; 6. Those who have recently used anti-inflammatory drugs or antioxidant drugs; 7. Long-term use of glucocorticoids or immunosuppressants; 8. History of allergy to esketamine or contraindications to use, serious risk of elevated blood pressure and intracranial pressure, poorly controlled or untreated hypertension, untreated or undertreated hyperthyroidism, gastrointestinal bleeding.; 9. Have psychiatric illness and other chronic pain or other conditions that may confound analgesic responses; 10. Emergency surgery or trauma patients; 11. Previous abdominal surgery or intraoperative history.

Design outcomes

Primary

MeasureTime frame
The incidence of PPCs within 7days postoperatively;

Secondary

MeasureTime frame
OI=PaO2/FiO2;PA-aDO2;Respiratory Index(RI);Esketamine Plasma Concentration ;Cytokines (TNF-a; IL-1ß);Pain score;Time to get out of bed after surgery;Consumptions of the opioids drugs;Incidences of adverse reactions;Hhospital stays;Drainage tube remove time;Postoperative recovery of gasarointestin;The incidence of chronic postsurgical pain;

Countries

China

Contacts

Public ContactLei Yao

Nantong First People's Hispital

yaoleijiangsu1987@163.com+86 188 6292 0110

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026